Fenwick & West advised Sema4 on the deal. Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, announced its agreement to acquire GeneDx, an...
Sema4’s Acquisition of GeneDx
Velo3D’s Public Listing on NYSE
Fenwick & West advised Velo3D on the deal. Velo3D Inc., a leading additive manufacturing technology company for high-value metal parts, announced its public listing on the New...